PubMed for id: 2036580661

Year	Number of Results
2011	1
2016	4
2017	1
2020	1
2021	2
2022	2
2023	3
2024	0

1

NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma.

Kubala JM, Laursen KB, Schreiner R, Williams RM, van der Mijn JC, Crowley MJ, Mongan NP, Nanus DM, Heller DA, Gudas LJ. Kubala JM, et al. Cancer Biol Ther. 2023 Dec 31;24(1):2170669. doi: 10.1080/15384047.2023.2170669. Cancer Biol Ther. 2023. PMID: 36722045 Free PMC article.

2

Transcriptional regulation of NDUFA4L2 by NFIB induces sorafenib resistance by decreasing reactive oxygen species in hepatocellular carcinoma.

Zhou L, Mao LH, Li X, Wang QL, Chen SY, Chen ZJ, Lei J, Liu HT, Liao SQ, Ran T, Li XQ, Zhou ZH, He S. Zhou L, et al. Cancer Sci. 2023 Mar;114(3):793-805. doi: 10.1111/cas.15648. Epub 2022 Nov 29. Cancer Sci. 2023. PMID: 36369883 Free PMC article.

3

Unique expression of the atypical mitochondrial subunit NDUFA4L2 in cerebral pericytes fine tunes HIF activity in response to hypoxia.

Mesa-Ciller C, Turiel G, Guajardo-Grence A, Lopez-Rodriguez AB, Egea J, De Bock K, Aragonés J, Urrutia AA. Mesa-Ciller C, et al. J Cereb Blood Flow Metab. 2023 Jan;43(1):44-58. doi: 10.1177/0271678X221118236. Epub 2022 Aug 4. J Cereb Blood Flow Metab. 2023. PMID: 35929074 Free PMC article.

4

NDUFA4L2 promotes glioblastoma progression, is associated with poor survival, and can be effectively targeted by apatinib.

Chen Z, Wei X, Wang X, Zheng X, Chang B, Shen L, Zhu H, Yang M, Li S, Zheng X. Chen Z, et al. Cell Death Dis. 2021 Apr 7;12(4):377. doi: 10.1038/s41419-021-03646-3. Cell Death Dis. 2021. PMID: 33828084 Free PMC article.

5

NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.

Liu Y, Nie X, Zhu J, Wang T, Li Y, Wang Q, Sun Z. Liu Y, et al. J Cell Mol Med. 2021 Jan;25(2):1221-1237. doi: 10.1111/jcmm.16193. Epub 2020 Dec 19. J Cell Mol Med. 2021. PMID: 33340241 Free PMC article.

6

NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.

Liu L, Lan G, Peng L, Xie X, Peng F, Yu S, Wang Y, Tang X. Liu L, et al. Ren Fail. 2016 Sep;38(8):1199-205. doi: 10.1080/0886022X.2016.1208517. Epub 2016 Jul 25. Ren Fail. 2016. PMID: 27453328

7

Overexpression of NDUFA4L2 is associated with poor prognosis in patients with colorectal cancer.

Lv Y, Nie SL, Zhou JM, Liu F, Hu YB, Jiang JR, Li N, Liu JS. Lv Y, et al. ANZ J Surg. 2017 Dec;87(12):E251-E255. doi: 10.1111/ans.13617. Epub 2016 May 25. ANZ J Surg. 2017. PMID: 27226356

8

NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma.

Lai RK, Xu IM, Chiu DK, Tse AP, Wei LL, Law CT, Lee D, Wong CM, Wong MP, Ng IO, Wong CC. Lai RK, et al. Clin Cancer Res. 2016 Jun 15;22(12):3105-17. doi: 10.1158/1078-0432.CCR-15-1987. Epub 2016 Jan 27. Clin Cancer Res. 2016. PMID: 26819450

9

Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma.

Minton DR, Fu L, Mongan NP, Shevchuk MM, Nanus DM, Gudas LJ. Minton DR, et al. Clin Cancer Res. 2016 Jun 1;22(11):2791-801. doi: 10.1158/1078-0432.CCR-15-1511. Epub 2016 Jan 18. Clin Cancer Res. 2016. PMID: 26783287 Free PMC article.

10

Induction of the mitochondrial NDUFA4L2 protein by HIF-1α decreases oxygen consumption by inhibiting Complex I activity.

Tello D, Balsa E, Acosta-Iborra B, Fuertes-Yebra E, Elorza A, Ordóñez Á, Corral-Escariz M, Soro I, López-Bernardo E, Perales-Clemente E, Martínez-Ruiz A, Enríquez JA, Aragonés J, Cadenas S, Landázuri MO. Tello D, et al. Cell Metab. 2011 Dec 7;14(6):768-79. doi: 10.1016/j.cmet.2011.10.008. Epub 2011 Nov 17. Cell Metab. 2011. PMID: 22100406 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year